Versant Vantage I, L.P.

Versant Vantage I, L.P. is a declared insider at 2 companies; the most frequent names are Repare Therapeutics Inc. and Aprea Therapeutics, Inc. In total, 110 filings cover trades dated from 7 October 2019 to 6 June 2022.

Market trades split into 3 purchases (€9.0M) and 5 sales (€8.5M). Netting one side against the other leaves €430k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2022: no purchases and 5 sales on the market.

Half of the purchases are above €2.7M and half below.

The newest entry dates from 7 June 2022: a transaction, in Repare Therapeutics Inc. The clock since the last published purchase (25 June 2020) now reads 2,327 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.